Health: Osteoporosis

Baroness Cumberlege
asked Her Majesty's Government:

What assessment they have made of the guidance from the National Institute for Health and Clinical Excellence on the use of drugs to prevent osteoporotic fractures in postmenopausal women; and [HL4836]

What discussions they have had with the National Institute for Health and Clinical Excellence regarding the development of guidance on the use of drugs to prevent osteoporotic fractures in postmenopausal women. [HL4837]

Baroness Royall of Blaisdon
We have had no discussions with the National Institute for Health and Clinical Excellence (NICE) regarding the development of guidance on the use of drugs to prevent osteoporotic fractures in postmenopausal women.

We have made no assessment of this draft guidance from NICE.